• About Us
  • Our Practice Areas
    • Banking & Financial Services
    • Competition & Antitrust
    • Digital & Tech
    • EU & International
    • Food & Drink
    • Green Transition
    • Healthcare, Life Sciences & Wellbeing
    • Trade & Investment (including EU-UK)
    • Transport, Travel & Logistics
  • Our Team
    • FIPRA International
    • Special Advisors
  • FIPRA Network
  • Latest News
  • Events
  • Careers
Skip to content

FIPRA

Search for:
Events

Resilience and emergency management are clear EU priorities

By Robert Madelin
Wednesday, 27 May 2020
Resilience and emergency management are clear EU priorities

In the latest FIPRA Network client call, held on May 26, the esteemed panel focused on risk and sought to assess the prospects for better risk policies across the board in Europe, in light of the lessons of the COVID19 crisis.

For the first time in a century, the world faces a highly infectious and previously unknown pathogen. HIV, Ebola, SARS have all created challenges since their appearance, but COVID19 has disrupted society more, and more widely. Facing a novel risk, societies are responding with the same tool-box for understanding and response that human beings use for all other risks and threats. We see many controversies, and some missed lessons from previous eras.

We are seeing cases where science advice has been thought too lax, and where it is thought too severe. There seems indeed to be not one science, but a range of sciences. Not only do experts in key fields (like epidemiology and public health) disagree with other experts in the same field, there are also differences of language between different disciplines (think of the problems caused by the epidemiological phrase ‘herd immunity’ or the behavioural science concern around ‘behavioural fatigue’).

We are seeing cases where the general population follows quite severe policy well, and others where policy is widely flouted, at least by subsections of the population at certain times.

As we see the start of an anguished debate about lessons to be learned in the field of public health, we wanted to examine more broadly what the current crisis reveals about the European model of science-driven risk management.

The conversation was led by Jacki Davis, our resident convenor and moderator. Jacki was in conversation with:

  • David Ball, Professor of risk management at Middlesex University,
  • Tapani Piha, a public health MD who has been both in Finland and EU public service,
  • Ed Humpherson, Director General for Regulation at the UK Statistics Authority,
  • Robert Madelin, Chairman of FIPRA and a former Health DG in the European Commission.

David Ball, David Seedhouse and Ed Humpherson are among the co-authors of the so-called “CAPUR Principles” for better risk management.

The CAPUR initiative was born of a sense that Europe could still do better on risk management in practice, and that ill-considered risk policy and practice tended to diminish European innovative drive, resilience and self-efficacy. Europe could so easily do better, by putting the values of society more explicitly at the foundation of any response to risk management. An intentionally and openly ethical approach would bolster trust and contribute to greater risk literacy.

CAPUR turned out to be a timely endeavour. Conceived and launched in 2018, CAPUR had delivered before the COVID-19 crisis, but the pandemic illustrated well what was at stake and how much low-hanging fruit there was, for any society or institution that wanted to improve its performance in uncertainty. There was great recognition in this, mature phase of the pandemic crisis in Europe, that society and families as well as governments, would have to take balanced decisions in the face of competing risks. Trade-offs were inevitable, and needed to be judged, because decisions were needed, and not paralysis or drift.

On the issue of trust, CAPUR followed Onora O’Neill’s vision: actors earned trust by showing the public sustained evidence of coherent and trustworthy behaviour. Scientists tended to be trusted because the science culture is generally respected, and because they are honest about what they do not know. But when scientists display the different perspectives that multiple disciplines can bring to a set of data, this can cause some doubt in some audiences. And not everyone sufficiently acknowledges that scientists have intellectual baggage, and values too.

Hence the emphasis placed by CAPUR on the inextricable ethical dimension of the risk arena.

On the issues of risk literacy, misinformation and the disinformation peddled by ‘bad actors’, there was agreement that the space for bad actors had increased in the Internet age. Mere misinformation was an equally dangerous, albeit less well understood threat to sound risk policy: societies should pay more attention both to fighting fake news and to ensuring that the right facts were well presented.

Political decision-makers were often reluctant to devote time and energy to being more honest about the context and limitations around numbers, although when they tried this, they invariably found the effort was worth the positive pay-offs. More difficult in adversarial situations was to discourage actors and media alike from turning numbers into “killer facts” and pass-fail proofs.

Everyone agreed that better participation by the public at large was a sound foundation for better risk decisions. The widening of the deliberative process required both sound design and careful institutional curation, if it was not to be instrumentalized by political forces for their own ends. Nevertheless, there was a sense that the greater the urgency of a decision and the greater the unknowns, the more valuable it could be to engage in depth with the values and the preferences and the questions of the public at large.

Finally, we asked ourselves whether there was space for lessons to be learned, not only from CAPUR but from the successes and the failures of the current global crisis. We felt on balance that our institutions were good at honest self-assessment but on the current showing tended to forget important lessons over time. Better collective commitment to resilience and to strong emergency management capacity was a clear priority for the EU, going forward. A blame-free learning process, looking to a better future as opposed to simply better bulwarks against future threats, was possible.

FIPRA’s Healthcare, Life Sciences & Wellbeing Practice

We work across a diverse range of issues including access to medicines, inter-sectoral collaboration, and value-based healthcare. We equally provide solutions around public health, health and wellbeing, digital health, and global health. Learn more about us HERE.

Written by
Robert Madelin
Senior Strategist and Special Advisor
Profile
Healthcare, Life Sciences & Wellbeing
Healthcare, Life Sciences & Wellbeing
We work across a diverse range of issues, including access to medicines, value-based healthcare and public health, inter-sectoral collaboration on health and wellbeing, digital health and global health.
More
Latest News
  • News
    Gerd Götz joins FIPRA as a Special Advisor on Green Transition
    17 March 2023
  • Analysis
    PFAS: rooting ambitions for a toxic-free environment in a manageable process
    10 March 2023
  • News
    Erwin Dhondt  joins FIPRA as a Special Advisor for Health Security
    22 February 2023
  • Analysis
    EU’s small but vital step to shipping decarbonisation: the maritime ETS 
    9 February 2023
  • Analysis
    European Parliament’s New Year Resolution: build a powerful but child-friendly online gaming industry
    19 January 2023
Some of our experts
  • Erwin Dhondt
    Erwin Dhondt
    Special Advisor - Health Security
  • Annie Hubert
    Annie Hubert
    Special Advisor - Regulatory
  • Sheela  Upadhyaya
    Sheela Upadhyaya
    Special Advisor - Rare Diseases
  • Tapani Piha
    Tapani Piha
    Special Advisor - Digital Health
  • Bernard Merkel
    Bernard Merkel
    Special Advisor - Healthcare
  • Daniel Furby
    Daniel Furby
    Senior Advisor - Healthcare, EU Economic Governance, Health Systems
  • John Bowis
    John Bowis
    Special Advisor - Healthcare
  • Carol Brosgart
    Carol Brosgart
    Special Advisor - Healthcare
  • FIPRA in Australia
    FIPRA in Australia
    is known locally as Richardson Coutts
    FIPRA in Australia
  • FIPRA in Austria
    FIPRA in Austria
    is known locally as Mastermind Public Affairs Consulting
    FIPRA in Austria
  • FIPRA in Belgium
    FIPRA in Belgium
    is known locally as Greenlane Public Affair
    FIPRA in Belgium
  • FIPRA in Canada
    FIPRA in Canada
    is known locally as Earnscliffe Strategy Group
    FIPRA in Canada
  • FIPRA in China
    FIPRA in China
    is known locally as Yuan Associates
    FIPRA in China
  • FIPRA in Croatia
    FIPRA in Croatia
    is known locally as Vlahovic Group
    FIPRA in Croatia
  • FIPRA in Czech Republic
    FIPRA in Czech Republic
    is known locally as PAN Solutions
    FIPRA in Czech Republic
  • FIPRA in Denmark
    FIPRA in Denmark
    is known locally as European Advisers
  • FIPRA in Estonia
    FIPRA in Estonia
    is known locally as META Advisory Group
    FIPRA in Estonia
  • FIPRA in France
    FIPRA in France
    is known locally as Cabinet Samman
    FIPRA in France
  • FIPRA in Georgia
    FIPRA in Georgia
    is known locally as BGI Advisory Services Group
    FIPRA in Georgia
  • FIPRA in Germany
    FIPRA in Germany
    is known locally as Miller & Meier Consulting
    FIPRA in Germany
  • FIPRA in Greece
    FIPRA in Greece
    is known locally as One Team S.A
    FIPRA in Greece
  • FIPRA in Hungary
    FIPRA in Hungary
    is known locally as CEC Group
    FIPRA in Hungary
  • FIPRA in India
    FIPRA in India
    is known locally as Chase India
    FIPRA in India
  • FIPRA in Ireland
    FIPRA in Ireland
    is known locally as Vulcan Consulting
    FIPRA in Ireland
  • FIPRA in Italy
    FIPRA in Italy
    is known locally as Telos A&S
    FIPRA in Italy
  • FIPRA in Japan
    FIPRA in Japan
    is known locally as GR Japan
    FIPRA in Japan
  • FIPRA in Korea
    FIPRA in Korea
    is known locally as FIPRA Korea
  • FIPRA in Latvia
    FIPRA in Latvia
    is known locally as Meta Advisory
    FIPRA in Latvia
  • FIPRA in Luxembourg
    FIPRA in Luxembourg
    is known locally as Huggard Consulting Group
    FIPRA in Luxembourg
  • FIPRA in Malta
    FIPRA in Malta
    is known locally as Maritimus Company Limited
    FIPRA in Malta
  • FIPRA in Mexico
    FIPRA in Mexico
    is known locally as InStrag
    FIPRA in Mexico
  • FIPRA in The Netherlands
    FIPRA in The Netherlands
    is known locally as Public Matters
    FIPRA in The Netherlands
  • FIPRA in Norway
    FIPRA in Norway
    is known locally as First House
    FIPRA in Norway
  • FIPRA in Poland
    FIPRA in Poland
    is known locally as CEC Group
    FIPRA in Poland
  • FIPRA in Portugal
    FIPRA in Portugal
    is known locally as Initium
  • FIPRA in Singapore
    FIPRA in Singapore
    is known locally as Landmark Public Affairs
    FIPRA in Singapore
  • FIPRA in Slovakia
    FIPRA in Slovakia
    is known locally as FIPRA Slovakia
  • FIPRA in Slovenia
    FIPRA in Slovenia
    is known locally as MC Public Affairs S.a.r.l.
    FIPRA in Slovenia
  • FIPRA in South Africa
    FIPRA in South Africa
    is known locally as Ethicore Political Lobbying
    FIPRA in South Africa
  • FIPRA in Spain
    FIPRA in Spain
    is known locally as Influence Spain
    FIPRA in Spain
  • FIPRA in Sweden
    FIPRA in Sweden
    is known locally as Hallvarsson & Halvarsson (H&H)
    FIPRA in Sweden
  • FIPRA in Switzerland
    FIPRA in Switzerland
    is known locally as Hirzel.Neef.Schmid.Counselors
    FIPRA in Switzerland
  • FIPRA in Tunisia
    FIPRA in Tunisia
    is known locally as Mediterranean Development Initiative
    FIPRA in Tunisia
  • FIPRA in Turkey
    FIPRA in Turkey
    is known locally as Stamina Public Affairs
    FIPRA in Turkey
  • FIPRA in Turkey
    FIPRA in Turkey
    is known locally as Stamina Public Affairs
  • FIPRA in Ukraine
    FIPRA in Ukraine
    is known locally as Stober Poltavets & Associates
    FIPRA in Ukraine
  • FIPRA in the United Kingdom
    FIPRA in the United Kingdom
    is known locally as Lexington
    FIPRA in the United Kingdom
  • FIPRA in the United States
    FIPRA in the United States
    is known locally as Alpine Group
    FIPRA in the United States
FIPRA Network

FIPRA

© FIPRA 2023.
All rights reserved.

Follow us on Twitter  Find us on LinkedIn

  • Privacy Policy
Explore
  • About Us
  • Our Practice Areas
  • Our Team
  • FIPRA Network
  • Latest News
  • Events
  • Careers
  • FIPRA Tools
  • Contact Us
Practice Areas
  • Banking & Financial Services
  • Competition & Antitrust
  • Digital & Tech
  • EU & International
  • Food & Drink
  • Green Transition
  • Healthcare, Life Sciences & Wellbeing
  • Trade & Investment (including EU-UK)
  • Transport, Travel & Logistics
Contact

info@fipra.com

Brussels Office  map
FIPRA International SRL
Rue de la Loi 227
Brussels 1040
+32 (0)2 613 28 28
Company number: 0733.774.811

London Office  map
FIPRA International Limited
201 Borough High Street
London
SE1 1JA
+44 (0)203 805 7770
Company number: 3936157